![](/img/cover-not-exists.png)
Fludarabine plus alemtuzumab versus fludarabine alone in patients with previously treated chronic lymphocytic leukaemia: a randomised phase 3 trial
Thomas Elter, Liana Gercheva-Kyuchukova, Halyna Pylylpenko, Tadesuz Robak, Branimir Jaksic, Grigoriy Rekhtman, Sławomira Kyrcz-Krzemień, Mykola Vatutin, Jingyang Wu, Cynthia Sirard, Michael Hallek, AnVolume:
12
Year:
2011
Language:
english
DOI:
10.1016/s1470-2045(11)70242-x
File:
PDF, 286 KB
english, 2011